COVID-19 vaccination-induced antibody responses and waning by age and comorbidity status in a large population-based prospective cohort study
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Nederland Ministerie van Volksgezondheid Welzijn en Sport
This publication has 18 references indexed in Scilit:
- Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serologyNature Communications, 2023
- Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort studyInternational Journal of Infectious Diseases, 2023
- Antibody response to third and fourth BNT162b2 mRNA booster vaccinations in healthcare workers in Tokyo, JapanJournal of Infection and Chemotherapy, 2022
- Omicron neutralizing antibody response following booster vaccination compared with breakthrough infectionMed, 2022
- Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN studyJournal of Infection, 2022
- Strong Decay of SARS-CoV-2 Spike Antibodies after 2 BNT162b2 Vaccine Doses and High Antibody Response to a Third Dose in Nursing Home ResidentsJournal of the American Medical Directors Association, 2022
- Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regressionThe Lancet, 2022
- Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccinesNature Medicine, 2022
- SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposureEuropean Journal of Internal Medicine, 2022
- Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infectionNature Medicine, 2021